Chantell Preston
Chantell Preston is a seasoned professional with 20+ years’ experience in healthcare operations and in the healthcare innovation ecosystem as an investor, advisor, and strategist. Chantell is distinguished by her ability to identify and develop sound business strategy. Throughout her career, she has helped organizations recognize their unique business advantage and position themselves as key […]
Laura Lyons
Laura has extensive experience in medical devices with rich expertise in clinical, quality and regulatory affairs. This experience spans across large and small companies, including Roche, Beckman Coulter, Inogen and SonarMed. Laura has held consistent executive leadership positions for over 20 years in quality, regulatory and clinical. Through her recent position as Vice President of […]
Kelly Mabry
Kelly Mabry is a technical leader passionate about bringing meaningful technologies from lab to market. She has developed comprehensive product development plans with a strong product foundation, developed supply chain & manufacturing strategies, and shaped regulatory submissions. Currently, she is the CEO of Cellia Science and a VIC Executive in Residence (EIR). Previously she was […]
Natalie Gassman
Natalie Gassman, PhD received a BA in chemistry from Michigan State University, where she was also a member of the Women’s Crew team. She earned a PhD from the University of California Los Angeles in chemistry in 2008. She held post-doctorate positions at the National Institute of Environmental Health Sciences and the Wake Forest University […]
Ajay Gupta
Ajay is Senior Partner Emeritus at McKinsey & Company. He brings 30 years of global experience across multiple healthcare segments. Ajay serves on Shirley Ryan Ability Lab Keystone Board; non-Executive Director at Healthium Medtech; Director at BJC Healthcare, Director at OnPoint Surgical, RAND Health Advisory Board, Innovaccer Advisory Council, as well as advisor to several […]
Paul Atkins
Dr. Atkins has a PhD in Physical Organic Chemistry from Kings College, University of London, and has over 35 years of global pharmaceutical experience in the development, manufacture, and commercialization of inhaled medicines. He previously served as CEO of Oriel Therapeutics a start-up company utilizing unique technology to facilitate inhaled drug delivery and powder movement. […]
Fenel Eloi
Fenel is a seasoned executive in the Life Sciences Sector. He was most recently the COO of Cell Signaling Technology, Inc., a privately held Life Sciences company, where he grew the business at a CAGR of 15% over a period of 12 years and provided leadership in the transformation of the company to a global […]
Bruce Young
Bruce A. Young, Ph.D., is a scientist and business professional with over 25 years experience spanning the worlds of academia, industry, and investment. As a faculty member of the Chemistry Department of Indiana University-Purdue University Indianapolis (IUPUI) Dr. Young taught a variety of courses at both the undergraduate and graduate levels, and oversaw an active, […]
Dennis Liotta
Dr. Liotta obtained his PhD degree at City University of New York and carried out postdoctoral research at Ohio State University, after which he joined the Emory faculty in 1976. He was promoted to full professor in 1988 and currently holds the Samuel Candler Dobbs Professorship at Emory. To date, he has supervised over 150 […]
Gordon Van Dusen
Gordon Van Dusen is currently a senior healthcare management consultant, entrepreneur and angel investor with over 30 years of experience serving in strategic management, business development and marketing executive capacities with both early and late stage biopharma, medical device and digital health companies. He most recently served as President & CEO of Flashback Technologies, Inc. a […]
Trevor W. Turner
Trevor W. Turner, M.D. RMSK is a board-certified Physical Medicine and Rehabilitation (PM&R) physician at Georgia Bone and Joint where he works as the Director of the Center for Regenerative Orthopedics. He specializes in minimally invasive image guided orthopedic procedures to place platelet rich plasma and autologous stem cell injections into damaged tissue to help patients […]
J. David Owens
David Owens is currently the President and CEO of BiologicsMD, Inc., a position he has held since 2013. He brings over 30 years of pharmaceutical and biotechnology management and commercialization experience. Mr. Owens has also been an active accredited angel investor since 2009 and has been a member of the Delaware Crossing Investor Group and the […]